NEW YORK, June 4 - Pasadena, Calif.-based Nanostream, a microfluidics developer, today announced $22 million in Series C funding.
The company said the round was lead by AEA Investors -- a New York firm created in 1969 to invest funds of the Rockefellers, Mellons and Harrimans -- and Lilly BioVentures, the venture capital arm of Eli Lilly.
Other investors included: Techno Venture Management of Munich, Germany, and Flagship Ventures of Cambridge, Mass., as well as private investors who had participated in previous funding rounds of $11 million.
Founded in 1999, the company manufactures a system of instruments, microfluidics cartridges, and software.